What We're Reading, July 11, 2016: US lawmakers who signed letters opposing the Medicare Part B demonstration received bigger monetary support from Big Pharma; e-cigarettes could push adolescents toward smoking cigarettes; and Hillary Clinton says she supports lowering Medicare enrollment age.
Lawmakers who were vocal in their opposition to CMS’ Medicare Part B demonstration proposal received significantly more financial support from the pharmaceutical industry than those who were not. Public Citizen reports that US representatives received 82% greater contributions (a total of $7,236,806 for 310 representatives) for their 2016 campaigns from the pharmaceutical and health products industry if they had signed either 1 of 2 letters that opposed the project. The 124 who did not, received a combined $1,585,857.
The FDA’s recent decision to regulate e-cigarettes could not have come at a more appropriate time. A new study released today in the journal Pediatrics has found that e-cigarette users had a 6-times greater likelihood of initiating cigarette use compared with those who did not use e-cigarettes. Further, the association was much stronger in the adolescent population interviewed for the study. The authors conclude that some of the e-cigarette users are teens who would not have smokes regular cigarettes if not exposed to vapes.
Two weeks before the Democratic National Convention, Hillary Clinton indicated that she supports a “public option” in health insurance. According to The Washington Post, the Clinton campaign released a statement that said she would support allowing people 55 and older to buy into Medicare. The statement also affirmed her support for increased funding for primary-care services at community-based centers in rural parts of the nation. Bernie Sanders is expected to endorse Clinton this week.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More